Detalhe da pesquisa
1.
CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.
Australas J Dermatol
; 64(2): 194-203, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892928
2.
VEXAS syndrome: A dermatological perspective.
Australas J Dermatol
; 63(4): 488-492, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197697
3.
Prolonged survival with the early use of a novel extracorporeal photopheresis regimen in patients with Sézary syndrome.
Blood
; 134(16): 1346-1350, 2019 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467061
4.
Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
Australas J Dermatol
; 62(1): e8-e18, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33368169
5.
Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
Curr Oncol Rep
; 20(4): 32, 2018 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572582
6.
The importance of differentiating between mycosis fungoides with CD30-positive large cell transformation and mycosis fungoides with coexistent primary cutaneous anaplastic large cell lymphoma.
J Am Acad Dermatol
; 84(1): 185-187, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334059
7.
Excellent treatment outcomes from low dose radiation therapy for primary cutaneous CD4+ small/medium T-Cell lymphoproliferative disorder.
Radiother Oncol
; 178: 109430, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455687
8.
International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies.
Blood Adv
; 7(21): 6639-6647, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648672
9.
Targeted Approaches to T-Cell Lymphoma.
J Pers Med
; 11(6)2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34072040
10.
Advances in Frontline Management of Peripheral T-cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(6): 368-378, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610499
11.
Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.
Leuk Lymphoma
; 62(2): 330-336, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33026266
12.
Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma.
Cancers (Basel)
; 12(11)2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33114606
13.
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Blood Adv
; 4(19): 4640-4647, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002132
14.
Brentuximab vedotin in T-cell lymphoma.
Expert Rev Hematol
; 12(1): 5-19, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30526166
15.
Lack of Durable Remission with Conventional-Dose Total Skin Electron Therapy for the Management of Sezary Syndrome and Multiply Relapsed Mycosis Fungoides.
Cancers (Basel)
; 11(11)2019 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31717353
16.
IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma.
Expert Opin Investig Drugs
; 27(8): 691-697, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30001170
17.
Ruxolitinib bridging therapy to allogeneic SCT for high-risk refractory subcutaneous panniculitis-like T-cell lymphoma.
Leuk Lymphoma
; 63(13): 3217-3221, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070587
18.
Long-term outcomes for allogeneic bone marrow transplantation in Sezary syndrome and mycosis fungoides.
Bone Marrow Transplant
; 57(11): 1724-1726, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36028756
19.
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
AIDS
; 31(13): 1839-1845, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28514279
20.
Pralatrexate and angioimmunoblastic T-cell lymphoma: time for a second look?
Leuk Lymphoma
; 61(9): 2031-2033, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32729765